In addition to its potential relevance in obesity, LAMA4 has been linked to the prognosis of gastric cancer and immune cell infiltration, suggesting LAMA4 as a therapeutic target for these conditions [22]. Here, LAMA4 is linked to obesity due to melanocortin 4 receptor deficiency.